133 related articles for article (PubMed ID: 15341256)
1. [Flow cytometric DNA analysis and neoadjuvant chemotherapy of cervix cancer (stage IB2-IIIB)].
Kornovskiĭ Ia; Gorchev G; Balev S; Ivanova F
Akush Ginekol (Sofiia); 2004; 43(3):37-41. PubMed ID: 15341256
[TBL] [Abstract][Full Text] [Related]
2. Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix.
Willén R; Himmelmann A; Långström-Einarsson E; Fernö M; Ranstam J; Baldetorp B; Skjaerris J; Prien-Larsen J; Tropé C; Stendahl U
Anticancer Res; 1993; 13(4):1187-96. PubMed ID: 8352543
[TBL] [Abstract][Full Text] [Related]
3. [Neoadjuvant chemotherapy in locally advanced squamous carcinoma of the uterine cervix (IB2 - IIIB stage)].
Kornovski Ia; Ianeva R; Gorchev G; Tsekov Kh; Uzunov S; Filev S
Akush Ginekol (Sofiia); 2002; 41(4):39-44. PubMed ID: 12516261
[No Abstract] [Full Text] [Related]
4. [Effect of neoadjuvant chemotherapy in the treatment of patients with stage IIIB cervical cancer].
Gorchev G; Kornovski Ia
Akush Ginekol (Sofiia); 2003; 42(6):21-4. PubMed ID: 15067810
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of patients with stage IIIb-IVa squamous cell carcinoma of the cervix following intra-arterial neoadjuvant chemotherapy.
Fujiwaki R; Maede Y; Ohnishi Y; Watanabe Y; Hata K; Miyazaki K
J Exp Clin Cancer Res; 1999 Jun; 18(2):143-6. PubMed ID: 10464699
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report.
Fuso L; Mazzola S; Marocco F; Ferrero A; Dompè D; Carus AP; Zola P
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S187-91. PubMed ID: 16185756
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma].
Cheng XD; Lü WG; Ye F; Chen HZ; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856
[TBL] [Abstract][Full Text] [Related]
8. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.
Kornovski Y; Gorchev G
J BUON; 2007; 12(1):57-63. PubMed ID: 17436403
[TBL] [Abstract][Full Text] [Related]
9. [Neoadjuvant chemotherapy before radiotherapy in treatment of patients with cervical carcinoma].
Li QS; Zhang XQ; Li DP; Sheng XG; Du XL; Song QQ
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):83-7. PubMed ID: 16640853
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy in stage III breast cancer.
Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
[TBL] [Abstract][Full Text] [Related]
11. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
Kim YB; Cho JH; Keum KC; Lee CG; Seong J; Suh CO; Kim GE
Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study.
Chen H; Liang C; Zhang L; Huang S; Wu X
Gynecol Oncol; 2008 Sep; 110(3):308-15. PubMed ID: 18606439
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma Long-term survival in a prospective, non-randomized study.
Kessler P; Grabenbauer G; Leher A; Bloch-Birkholz A; Vairaktaris E; Neukam FW
Br J Oral Maxillofac Surg; 2008 Jan; 46(1):1-5. PubMed ID: 17931758
[TBL] [Abstract][Full Text] [Related]
14. [Improvement of postoperative radiotherapy in the complex treatment of stage II-III cervical cancer].
Kreĭnina IuM; Titova VA; Shipilova AN; Povarova EV; Shevchenko LN
Vopr Onkol; 2006; 52(1):83-8. PubMed ID: 16715711
[TBL] [Abstract][Full Text] [Related]
15. Are increased tumor aneuploidy and heightened cell proliferation along with heterogeneity associated with patient outcome for carcinomas of the uterine cervix? A combined analysis of subjects treated in RTOG 9001 and a single-institution trial.
Wolfson AH; Winter K; Crook W; Krishan A; Grigsby PW; Markoe AM; Morris M; Gaffney DK; Eifel PJ; Lucci JA
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):111-7. PubMed ID: 17919835
[TBL] [Abstract][Full Text] [Related]
16. [The role of the preoperative radiochemotherapy and the role of neoadjuvant chemotherapy before radical Wertheim-Meigs hysterectomy for cervical cancer stage I B - II B].
Ivanov S; Kŭrlov A
Akush Ginekol (Sofiia); 2006; 45(2):28-31. PubMed ID: 16637300
[TBL] [Abstract][Full Text] [Related]
17. DNA flow cytometry: a predictor of a high-risk group in cervical cancer.
Anton M; Nenutil R; Rejthar A; Kopecny J; Ptackova B; Zaloudik J
Cancer Detect Prev; 1997; 21(3):242-6. PubMed ID: 9167041
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer and neoadjuvant therapy: any predictive marker?
Vyzula R; Dusek L; Zaloudík J; Demlová R; Klimes D; Selvekerová S
Neoplasma; 2004; 51(6):471-80. PubMed ID: 15640958
[TBL] [Abstract][Full Text] [Related]
19. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]